ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) EV to EBIT (2013 - 2023)

Updated

ProPhase Labs' (PRPH) EV to EBIT came in at 13.86 for Q1 2023, up 333.5% from 3.20 a year earlier and up 135.8% from the prior quarter.

Analysis

ProPhase Labs (PRPH) EV to EBIT (2013 - 2023) Analysis & Trends

For the trailing twelve months through Mar 31, 2023, EV to EBIT at ProPhase Labs was 5.28; for FY2022, it was 5.88, down 38.6% from FY2021.

  • In prior years, ProPhase Labs' EV to EBIT was 9.58 in FY2021.
  • The Q1 2023 figure stands as the highest quarterly EV to EBIT since Q4 2013.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 5.88 (Q4 2022), 3.71 (Q3 2022) and 4.77 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 13.86
Dec 31, 2022 5.88
Sep 30, 2022 3.71
Jun 30, 2022 4.77
Mar 31, 2022 3.20
Dec 31, 2021 9.58
Dec 31, 2013 60.54
Sep 30, 2013 111.07
Jun 30, 2013 207.30
API Access

ProPhase Labs EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=PRPH&period=max&api_key=YOUR_API_KEY